Healthcare provider profile · identity verified

Lukas Holt, D.O.

Family Practice · FAR ROCKAWAY, NY · NPI 1033641378

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	328	164
Amlodipine Besylate	Amlodipine Besylate	230	120
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	199	65
Losartan Potassium	Losartan Potassium	174	76
Levothyroxine Sodium	Levothyroxine Sodium	128	57
Lisinopril	Lisinopril	124	64
Albuterol Sulfate Hfa	Albuterol Sulfate	111	59
Atenolol	Atenolol	93	42
Tamsulosin Hcl	Tamsulosin Hcl	93	40
Hydrochlorothiazide	Hydrochlorothiazide	91	40
Gabapentin	Gabapentin	84	38
Ibuprofen	Ibuprofen	79	48
Metoprolol Tartrate	Metoprolol Tartrate	70	36
Simvastatin	Simvastatin	64	28
Metformin Hcl	Metformin Hcl	58	29
Metformin Hcl Er	Metformin Hcl	58	27
Famotidine	Famotidine	57	33
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	57	23
Fluticasone Propionate	Fluticasone Propionate	56	37
Furosemide	Furosemide	53	35
Allopurinol	Allopurinol	52	23
Trazodone Hcl	Trazodone Hcl	52	19
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	51	17
Triamcinolone Acetonide	Triamcinolone Acetonide	49	29
Pantoprazole Sodium	Pantoprazole Sodium	47	29
Prednisone	Prednisone	47	28
Glipizide	Glipizide	45	21
Colchicine	Colchicine	44	21
Lorazepam	Lorazepam	41	14
Alendronate Sodium	Alendronate Sodium	40	22
Terazosin Hcl	Terazosin Hcl	39	18
Spiriva Respimat	Tiotropium Bromide	38	15
Clopidogrel	Clopidogrel Bisulfate	37	17
Finasteride	Finasteride	37	16
Ozempic	Semaglutide	37	11
Lovastatin	Lovastatin	34	12
Metoprolol Succinate	Metoprolol Succinate	34	17
Potassium Chloride	Potassium Chloride	28	16
Tramadol Hcl	Tramadol Hcl	28	14
Jardiance	Empagliflozin	27	13
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	27	14
Tizanidine Hcl	Tizanidine Hcl	27	19
Meloxicam	Meloxicam	26	12
Duloxetine Hcl	Duloxetine Hcl	25	14
Omeprazole	Omeprazole	25	11
Clonazepam	Clonazepam	23	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	23	suppressed
Azelastine Hcl	Azelastine Hcl	22	suppressed
Clobetasol Propionate	Clobetasol Propionate	22	13
Ropinirole Hcl	Ropinirole Hcl	22	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	21	18
Humulin N	Insulin Nph Human Isophane	20	11
Neomycin-Polymyxin-Dexameth	Neomycin/Polymyxin B/Dexametha	20	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	20	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	19	suppressed
Pradaxa	Dabigatran Etexilate Mesylate	19	11
Pregabalin	Pregabalin	19	11
Acyclovir	Acyclovir	17	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	17	suppressed
Hydrocortisone	Hydrocortisone	17	14
Hydromorphone Hcl	Hydromorphone Hcl	17	suppressed
Temazepam	Temazepam	17	suppressed
Carvedilol	Carvedilol	16	suppressed
Mirtazapine	Mirtazapine	16	suppressed
Sertraline Hcl	Sertraline Hcl	16	suppressed
Bupropion Xl	Bupropion Hcl	15	suppressed
Methocarbamol	Methocarbamol	15	suppressed
Ondansetron Odt	Ondansetron	15	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	15	12
Fluoxetine Hcl	Fluoxetine Hcl	14	suppressed
Hydralazine Hcl	Hydralazine Hcl	14	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	14	suppressed
Ondansetron Hcl	Ondansetron Hcl	14	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	14	suppressed
Paroxetine Hcl	Paroxetine Hcl	14	suppressed
Alvesco	Ciclesonide	13	suppressed
Amoxicillin	Amoxicillin	13	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	13	suppressed
Chlorthalidone	Chlorthalidone	13	suppressed
Latanoprost	Latanoprost	13	suppressed
Propranolol Hcl	Propranolol Hcl	13	suppressed
Baclofen	Baclofen	12	suppressed
Cephalexin	Cephalexin	12	12
Montelukast Sodium	Montelukast Sodium	12	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	11	suppressed
Buspirone Hcl	Buspirone Hcl	11	suppressed
Citalopram Hbr	Citalopram Hydrobromide	11	suppressed
Spironolactone	Spironolactone	11	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	11	suppressed
Topiramate	Topiramate	11	suppressed
Warfarin Sodium	Warfarin Sodium	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error